| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nuvectis Pharma, Inc. (NVCT) has 7 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. NVCT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.68M | $72.49M | - | |
| 10% | 3.14M | $61.85M | - | |
| Other | 1.81M | $35.62M | - | |
| Other | 1.79M | $35.36M | - | |
| VP | 200.1K | $3.95M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2023 | Bentsur Ron64 | Chairman &CEO | Buy | 1,080 | $11.21 | $12,105.20 | - | -7.0% | -44.7% | |
| Oct 5, 2023 | Bentsur Ron64 | Chairman &CEO | Buy | 3,220 | $11.01 | $35,455.00 | - | -23.8% | -43.9% | |
| Aug 16, 2023 | Bentsur Ron64 | Chairman &CEO | Buy | 350 | $14.61 | $5,112.15 | - | -40.9% | -55.9% | |
| Aug 11, 2023 | Bentsur Ron64 | Chairman &CEO | Buy | 300 | $14.73 | $4,418.40 | - | -46.2% | -55.7% | |
| Jul 31, 2023 | Mosseri Marlio Charles46 | 10% Owner | Buy | 860 | $13.88 | $11,936.80 | - | -40.4% | -53.7% | |
| Jul 28, 2023 | Mosseri Marlio Charles46 | 10% Owner | Buy | 2,584 | $13.91 | $35,943.44 | - | -35.8% | -49.9% | |
| Jul 27, 2023 | Mosseri Marlio Charles46 | 10% Owner | Buy | 1,556 | $13.98 | $21,752.88 | - | -36.3% | -50.7% | |
| Jul 26, 2023 | Mosseri Marlio Charles46 | 10% Owner | Buy | 10,000 | $13.97 | $139,700.00 | +0.4% | -34.8% | -52.2% | |
| Jul 21, 2023 | Bentsur Ron64 | Chairman &CEO | Buy | 335 | $14.92 | $4,997.85 | - | -39.6% | -55.3% | |
| Jul 21, 2023 | Mosseri Marlio Charles46 | 10% Owner | Buy | 8,238 | $14.47 | $119,224.44 | +0.2% | -39.6% | -55.3% |